beta

ACHN

Achillion Pharmaceuticals Inc.

Achn

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Achillion Pharmaceuticals Inc is a biotechnology company. It is engaged in the discovery and development of innovative small-molecule drug therapies for infectious diseases and immune system disorders.

Market Cap: 396 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.achillion.com

Shares Outstanding: 138 Million

Float: 138 Million

Dividend: 0.0 (0.0%)

Beta: 1.356592

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 6.08 Million

Ethical Flags

Animal testing

Longest drawdown: 1201 trading days

From: 2015-01-23 To: 2019-10-17

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud